Cleocin: Potent Antibiotic for Serious Bacterial Infections
Cleocin
Similar products
Cleocin (clindamycin) is a lincosamide antibiotic prescribed for the treatment of serious infections caused by susceptible anaerobic bacteria, gram-positive organisms, and certain protozoa. It is a critical therapeutic agent in both hospital and outpatient settings, particularly when penicillin is contraindicated or ineffective. Available in oral capsules, topical solutions, and injectable forms, Cleocin provides clinicians with a versatile tool to combat a range of moderate to severe infections. Its mechanism of action involves inhibition of bacterial protein synthesis, effectively halting the growth and spread of pathogenic organisms.
Features
- Active pharmaceutical ingredient: Clindamycin phosphate or clindamycin hydrochloride
- Available formulations: 150 mg and 300 mg oral capsules; topical gel, lotion, and solution; vaginal cream; intravenous and intramuscular injections
- Mechanism: Binds to the 50S ribosomal subunit, inhibiting bacterial protein synthesis
- Spectrum: Effective against aerobic gram-positive cocci, anaerobic gram-negative bacilli, and anaerobic gram-positive non-spore-forming bacilli
- Bioavailability: Approximately 90% for oral administration; not significantly affected by food
Benefits
- Provides potent bactericidal activity against a broad spectrum of anaerobic pathogens
- Effective alternative for patients with penicillin allergies or resistant organisms
- Multiple administration routes allow for tailored treatment approaches
- Rapid tissue penetration ensures therapeutic concentrations at infection sites
- Demonstrated efficacy in deep-seated infections and abscesses
- Well-established safety profile with extensive clinical experience
Common use
Cleocin is commonly prescribed for serious infections including: septicemia, intra-abdominal infections, lower respiratory tract infections, gynecological infections, skin and soft tissue infections, bone and joint infections, and dental infections. It is particularly valuable in treating anaerobic infections below the diaphragm, including those caused by Bacteroides fragilis. The topical formulation is indicated for acne vulgaris, while the vaginal cream is used for bacterial vaginosis.
Dosage and direction
Oral administration:
Adults: 150-450 mg every 6 hours
Children: 8-20 mg/kg/day divided into 3-4 equal doses
Parenteral administration:
Serious infections: 600-2700 mg/day IV or IM in 2-4 divided doses
Life-threatening infections: Up to 4800 mg/day IV
Topical administration:
Apply thin film to affected area twice daily
Dosage should be adjusted in patients with severe hepatic impairment. Treatment should continue for at least 10 days in β-hemolytic streptococcal infections to prevent rheumatic fever.
Precautions
Patients should be monitored for the development of pseudomembranous colitis, which may occur during or several weeks after antibiotic treatment. Use with caution in patients with gastrointestinal disease, particularly colitis. Hepatic and renal function should be monitored during prolonged therapy. May cause overgrowth of nonsusceptible organisms, particularly fungi. Topical application may cause irritation, and contact with eyes, mouth, and mucous membranes should be avoided.
Contraindications
Hypersensitivity to clindamycin, lincomycin, or any component of the formulation. History of regional enteritis, ulcerative colitis, or antibiotic-associated colitis. Not for intrathecal administration. Oral form contraindicated in patients unable to swallow capsules whole.
Possible side effect
Common: Nausea, vomiting, diarrhea, abdominal pain, skin rash, pruritus
Serious: Pseudomembranous colitis (may be fatal), severe skin reactions (Stevens-Johnson syndrome, toxic epidermal necrolysis), anaphylaxis, blood dyscrasias (neutropenia, thrombocytopenia), hepatic dysfunction, esophageal ulceration
Drug interaction
May potentiate neuromuscular blocking agents. Concurrent use with erythromycin may antagonize clindamycin’s antibacterial effect. Kaolin-pectin antidiarrheals may decrease absorption. May enhance the effect of warfarin; monitor INR closely.
Missed dose
If a dose is missed, take it as soon as remembered unless it is almost time for the next dose. Do not double doses. Maintain regular dosing schedule to ensure consistent antibiotic levels.
Overdose
Symptoms may include severe gastrointestinal distress. General supportive measures are indicated. Hemodialysis and peritoneal dialysis are not effective for removal. No specific antidote exists.
Storage
Store at controlled room temperature (20-25°C/68-77°F). Protect from light and moisture. Keep all medications out of reach of children. Do not use after expiration date.
Disclaimer
This information is for educational purposes only and does not constitute medical advice. Always consult a healthcare professional for diagnosis and treatment recommendations. Individual response to medication may vary. Not all possible uses, interactions, or adverse effects are listed here.
Reviews
“Cleocin has been invaluable in our surgical department for preventing and treating post-operative infections, particularly those involving anaerobic organisms. The IV formulation provides rapid therapeutic levels when time is critical.” - Infectious Disease Specialist
“While effective, we maintain heightened vigilance for C. difficile colitis, especially in elderly patients receiving prolonged courses. The benefits generally outweigh risks when used appropriately.” - Hospital Pharmacist
“Topical clindamycin remains a cornerstone in our acne treatment protocols, particularly when combined with benzoyl peroxide. Patients appreciate the multiple formulation options.” - Dermatologist